Evaluation of Skin Viscoelasticity in Type 1 Neurofibromatosis Patients
Neurofibromatosis type 1 (NF1) is a frequent autosomal dominant disease characterized by cutaneous benign tumors called neurofibromas. Surgery takes an important place in managing these skin disorders. However, skin distensibility and softness of NF1 patients quickly offset the surgical benefit. The...
Saved in:
Published in | Skin pharmacology and physiology Vol. 19; no. 1; pp. 22 - 27 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Basel, Switzerland
S. Karger AG
01.01.2006
|
Subjects | |
Online Access | Get full text |
ISSN | 1660-5527 1660-5535 |
DOI | 10.1159/000089140 |
Cover
Abstract | Neurofibromatosis type 1 (NF1) is a frequent autosomal dominant disease characterized by cutaneous benign tumors called neurofibromas. Surgery takes an important place in managing these skin disorders. However, skin distensibility and softness of NF1 patients quickly offset the surgical benefit. The aim of this study was to determine the rheological behavior of neurofibromas and compare it with healthy skin in an attempt to comprehend what leads to this phenomenon. Thirty patients were admitted to this study. A group of 24 healthy control subjects was also included. The skin elasticity was assessed by a noninvasive in vivo suction device (Cutometer) including 5 consecutive suctions. The assessments were performed on neurofibroma skin, the supposedly healthy skin around neurofibromas and the healthy skin of control subjects. The extensibility at the first and the fifth traction in NF1 patients (neurofibromas and the supposedly healthy skin around it) was significantly different compared to the healthy skin of control subjects. The viscoelastic parameters obtained from the neurofibromas were significantly different in comparison to those obtained from the supposedly healthy skin of NF1 patients and the healthy skin of control subjects. The rheological profiles of the neurofibromas and the apparent healthy skin of NF1 patients demonstrated a hyperextensibility behavior, but in neurofibromas, the skin was unable to return to its initial position at the end of the stretch. |
---|---|
AbstractList | Neurofibromatosis type 1 (NF1) is a frequent autosomal dominant disease characterized by cutaneous benign tumors called neurofibromas. Surgery takes an important place in managing these skin disorders. However, skin distensibility and softness of NF1 patients quickly offset the surgical benefit. The aim of this study was to determine the rheological behavior of neurofibromas and compare it with healthy skin in an attempt to comprehend what leads to this phenomenon. Thirty patients were admitted to this study. A group of 24 healthy control subjects was also included. The skin elasticity was assessed by a noninvasive in vivo suction device (Cutometer) including 5 consecutive suctions. The assessments were performed on neurofibroma skin, the supposedly healthy skin around neurofibromas and the healthy skin of control subjects. The extensibility at the first and the fifth traction in NF1 patients (neurofibromas and the supposedly healthy skin around it) was significantly different compared to the healthy skin of control subjects. The viscoelastic parameters obtained from the neurofibromas were significantly different in comparison to those obtained from the supposedly healthy skin of NF1 patients and the healthy skin of control subjects. The rheological profiles of the neurofibromas and the apparent healthy skin of NF1 patients demonstrated a hyperextensibility behavior, but in neurofibromas, the skin was unable to return to its initial position at the end of the stretch. Neurofibromatosis type 1 (NF1) is a frequent autosomal dominant disease characterized by cutaneous benign tumors called neurofibromas. Surgery takes an important place in managing these skin disorders. However, skin distensibility and softness of NF1 patients quickly offset the surgical benefit. The aim of this study was to determine the rheological behavior of neurofibromas and compare it with healthy skin in an attempt to comprehend what leads to this phenomenon. Thirty patients were admitted to this study. A group of 24 healthy control subjects was also included. The skin elasticity was assessed by a noninvasive in vivo suction device (Cutometer) including 5 consecutive suctions. The assessments were performed on neurofibroma skin, the supposedly healthy skin around neurofibromas and the healthy skin of control subjects. The extensibility at the first and the fifth traction in NF1 patients (neurofibromas and the supposedly healthy skin around it) was significantly different compared to the healthy skin of control subjects. The viscoelastic parameters obtained from the neurofibromas were significantly different in comparison to those obtained from the supposedly healthy skin of NF1 patients and the healthy skin of control subjects. The rheological profiles of the neurofibromas and the apparent healthy skin of NF1 patients demonstrated a hyperextensibility behavior, but in neurofibromas, the skin was unable to return to its initial position at the end of the stretch. Copyright © 2006 S. Karger AG, Basel Neurofibromatosis type 1 (NF1) is a frequent autosomal dominant disease characterized by cutaneous benign tumors called neurofibromas. Surgery takes an important place in managing these skin disorders. However, skin distensibility and softness of NF1 patients quickly offset the surgical benefit. The aim of this study was to determine the rheological behavior of neurofibromas and compare it with healthy skin in an attempt to comprehend what leads to this phenomenon. Thirty patients were admitted to this study. A group of 24 healthy control subjects was also included. The skin elasticity was assessed by a noninvasive in vivo suction device (Cutometer) including 5 consecutive suctions. The assessments were performed on neurofibroma skin, the supposedly healthy skin around neurofibromas and the healthy skin of control subjects. The extensibility at the first and the fifth traction in NF1 patients (neurofibromas and the supposedly healthy skin around it) was significantly different compared to the healthy skin of control subjects. The viscoelastic parameters obtained from the neurofibromas were significantly different in comparison to those obtained from the supposedly healthy skin of NF1 patients and the healthy skin of control subjects. The rheological profiles of the neurofibromas and the apparent healthy skin of NF1 patients demonstrated a hyperextensibility behavior, but in neurofibromas, the skin was unable to return to its initial position at the end of the stretch.Neurofibromatosis type 1 (NF1) is a frequent autosomal dominant disease characterized by cutaneous benign tumors called neurofibromas. Surgery takes an important place in managing these skin disorders. However, skin distensibility and softness of NF1 patients quickly offset the surgical benefit. The aim of this study was to determine the rheological behavior of neurofibromas and compare it with healthy skin in an attempt to comprehend what leads to this phenomenon. Thirty patients were admitted to this study. A group of 24 healthy control subjects was also included. The skin elasticity was assessed by a noninvasive in vivo suction device (Cutometer) including 5 consecutive suctions. The assessments were performed on neurofibroma skin, the supposedly healthy skin around neurofibromas and the healthy skin of control subjects. The extensibility at the first and the fifth traction in NF1 patients (neurofibromas and the supposedly healthy skin around it) was significantly different compared to the healthy skin of control subjects. The viscoelastic parameters obtained from the neurofibromas were significantly different in comparison to those obtained from the supposedly healthy skin of NF1 patients and the healthy skin of control subjects. The rheological profiles of the neurofibromas and the apparent healthy skin of NF1 patients demonstrated a hyperextensibility behavior, but in neurofibromas, the skin was unable to return to its initial position at the end of the stretch. |
Author | Moreno, J.C. Marty, J.P. Razzouq, N. Paul, M. Astier, A. Wolkenstein, P. Mimoun, N. Lantieri, L. |
Author_xml | – sequence: 1 givenname: N. surname: Mimoun fullname: Mimoun, N. – sequence: 2 givenname: N. surname: Razzouq fullname: Razzouq, N. – sequence: 3 givenname: P. surname: Wolkenstein fullname: Wolkenstein, P. – sequence: 4 givenname: J.C. surname: Moreno fullname: Moreno, J.C. – sequence: 5 givenname: J.P. surname: Marty fullname: Marty, J.P. – sequence: 6 givenname: L. surname: Lantieri fullname: Lantieri, L. – sequence: 7 givenname: A. surname: Astier fullname: Astier, A. – sequence: 8 givenname: M. surname: Paul fullname: Paul, M. |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/16247246$$D View this record in MEDLINE/PubMed |
BookMark | eNptkM9LwzAUx4NM3A89eBakeBA81CVZkzRHGXMKooLTa0nbV8nWNjNphf33RjsnDHN54b3P9_H4DFGvNjUgdErwNSFMjrF_sSQRPkADwjkOGZuw3u5PRR8NnVtiTLkg_Aj1CaeRoBEfoPnsU5WtarSpA1MELytdB2_aZQZK5Rqd6WYT-NZis4aABI_QWlPo1JpKNcZpFzz7KNSNO0aHhSodnGzrCL3ezhbTu_DhaX4_vXkIs4iyJkylJIClgIJMVCS5VAApZ0zFnKaM5VkWxaKIVBwLWpAUcqkIZzSmUqSEynwyQpfd3rU1Hy24Jqn8tVCWqgbTukRgIgWLpQcv9sClaW3tb0soZZTLSAoPnW-hNq0gT9ZWV8pukl8_HrjqgMwa5ywUfwhOvt0nO_eeHe-x3t6P2cYqXf6bOOsSK2Xfwe52d9MvyLSMJA |
CitedBy_id | crossref_primary_10_1016_j_anplas_2011_08_006 crossref_primary_10_1016_j_bjps_2011_11_034 crossref_primary_10_1016_j_neuchi_2010_02_021 crossref_primary_10_1016_j_joms_2012_03_026 crossref_primary_10_1186_s40349_016_0065_8 crossref_primary_10_1097_SCS_0000000000004685 crossref_primary_10_14228_jpr_v1i1_32 crossref_primary_10_1016_j_jcms_2015_06_023 crossref_primary_10_1097_PRS_0000000000002021 crossref_primary_10_1097_PRS_0b013e3181d180e9 crossref_primary_10_1186_s13023_022_02223_x |
Cites_doi | 10.1016%2F1076-0512%2895%2900057-7 10.1159%2F000246427 10.1046%2Fj.1365-2362.1997.2050752.x 10.1034%2Fj.1600-0846.2000.006004239.x 10.1159%2F000246472 10.1001%2Farchderm.136.10.1207 10.1111%2Fj.1750-3639.1995.tb00589.x 10.1111%2Fj.1525-1470.1996.tb00725.x 10.1046%2Fj.1365-2230.2000.00627.x 10.1046%2Fj.1365-2133.2001.04067.x 10.1046%2Fj.1365-2362.1996.154303.x 10.1111%2Fj.1749-6632.1986.tb48079.x 10.1016%2FS0092-8674%2801%2900245-8 10.1111%2Fj.1365-2230.1994.tb01140.x 10.1002%2Fjnr.1142 10.1080%2F000155500750012135 10.1016%2FS0190-9622%2896%2990601-5 10.1084%2Fjem.194.1.57 10.1080%2F000155599750010724 10.1046%2Fj.1365-4362.1997.00041.x 10.1111%2Fj.1365-2133.1994.tb03377.x 10.1046%2Fj.1523-1747.1999.00609.x 10.1016%2FS1471-4914%2801%2901955-4 10.1016%2FS0001-4001%2899%2980095-6 |
ContentType | Journal Article |
Copyright | 2006 S. Karger AG, Basel (c) 2006 S. Karger AG, Basel Copyright S. Karger AG Dec 2005 |
Copyright_xml | – notice: 2006 S. Karger AG, Basel – notice: (c) 2006 S. Karger AG, Basel – notice: Copyright S. Karger AG Dec 2005 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QO 7U7 7X7 7XB 88E 8AO 8FD 8FI 8FJ 8FK ABUWG AFKRA BENPR C1K CCPQU FR3 FYUFA GHDGH K9. M0S M1P P64 PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 |
DOI | 10.1159/000089140 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Biotechnology Research Abstracts Toxicology Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Technology Research Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central Environmental Sciences and Pollution Management ProQuest One Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni) Medical Database Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Technology Research Database ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Pharma Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Biotechnology Research Abstracts Health and Medicine Complete (Alumni Edition) Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) Toxicology Abstracts ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE CrossRef Technology Research Database MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1660-5535 |
EndPage | 27 |
ExternalDocumentID | 937949711 16247246 10_1159_000089140 89140 |
Genre | Journal Article |
GroupedDBID | --- 0R~ 0~5 0~B 123 1CY 30W 328 3O. 3V. 4.4 53G 7X7 88E 8AO 8FI 8FJ AAYIC ABJNI ABPAZ ABUWG ACGFO ACGFS ACIWK ACPRK ACPSR ADBBV AENEX AEYAO AFJJK AFKRA AFRAH AHMBA ALDHI ALMA_UNASSIGNED_HOLDINGS AZPMC BENPR BPHCQ BVXVI CAG CCPQU COF CYUIP DU5 E0A EBS EJD EMOBN F5P FB. FYUFA HMCUK HZ~ IAO IHR IY7 KUZGX M1P O1H O9- P2P PQQKQ PROAC PSQYO RKO RXVBD UJ6 UKHRP AAYXX ABBTS ABWCG AHFRZ CITATION ITC PHGZM PHGZT PJZUB PPXIY PUEGO CGR CUY CVF ECM EIF NPM 7QO 7U7 7XB 8FD 8FK C1K FR3 K9. P64 PKEHL PQEST PQUKI PRINS 7X8 |
ID | FETCH-LOGICAL-c425t-b991e097ef13a4969aeeb655a862b55dcc487f4a8872f1bed9a16528297b129d3 |
IEDL.DBID | 7X7 |
ISSN | 1660-5527 |
IngestDate | Fri Sep 05 01:46:52 EDT 2025 Sat Aug 23 14:10:29 EDT 2025 Wed Feb 19 01:42:49 EST 2025 Thu Apr 24 23:03:47 EDT 2025 Wed Oct 01 06:30:59 EDT 2025 Thu Aug 29 12:04:13 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Skin viscoelasticity Neurofibromatosis type 1 Cutometer |
Language | English |
License | Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. https://www.karger.com/Services/SiteLicenses (c) 2006 S. Karger AG, Basel |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c425t-b991e097ef13a4969aeeb655a862b55dcc487f4a8872f1bed9a16528297b129d3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
PMID | 16247246 |
PQID | 225269497 |
PQPubID | 29225 |
PageCount | 6 |
ParticipantIDs | proquest_miscellaneous_70197589 proquest_journals_225269497 pubmed_primary_16247246 crossref_primary_10_1159_000089140 karger_primary_89140 crossref_citationtrail_10_1159_000089140 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2006-01-01 |
PublicationDateYYYYMMDD | 2006-01-01 |
PublicationDate_xml | – month: 01 year: 2006 text: 2006-01-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | Basel, Switzerland |
PublicationPlace_xml | – name: Basel, Switzerland – name: Switzerland – name: Basel |
PublicationTitle | Skin pharmacology and physiology |
PublicationTitleAlternate | Skin Pharmacol Physiol |
PublicationYear | 2006 |
Publisher | S. Karger AG |
Publisher_xml | – name: S. Karger AG |
References | Grudeva-Popova J, Dobrev H: Biomechanical measurement of skin distensibility in scleroderma of Buschke with multiple myeloma. Clin Exp Dermatol 2000;25:247-249.1084450810.1046%2Fj.1365-2230.2000.00627.x Fong SSL, Hung LK, Cheng JCY: The Cutometer and ultrasonography in the assessment of postburn hypertrophic scar - A preliminary study. Burns 1997;23:S12-S18. Henry F, Goffin V, Piérard-Franchimont C, Piérard GE: Mechanical properties of skin in Ehlers-Danlos syndrome, types I, II and III. Pediatr Dermatol 1996;13:464-467.898705410.1111%2Fj.1525-1470.1996.tb00725.x Chanoki M, Ishii M, Fukai K, Kobayashi H, Hamada T, Muragaki Y, Ooshima A: Immunohistochemical localization of type I, III, IV, V, and VI collagens and laminin in neurofibroma and neurofibrosarcoma.Am J Dermopathol 1991;13:365-373. Lakkis MM, Tennekoon GI: Neurofibromatosis type 1: answers from animal models. J Neurosci Res 2001;65:191-194.1149435310.1002%2Fjnr.1142 Dobrev H: In vivo study of skin mechanical properties in psoriasis vulgaris. Acta Derm Venereol 2000;80:263-266.1102885810.1080%2F000155500750012135 Peltonen J, Penttinnen R, Larjava H, Aho HJ: Collagens in neurofibromas and neurofibroma cell cultures. Ann NY Acad Sci1986;486:260-270.310539110.1111%2Fj.1749-6632.1986.tb48079.x Zhang LQ, Laato M, Muona P, Kalimo H, Peltonen J: Normal and hypertrophic scars: quantification and localization of messenger RNAs for type I, III and VI collagens. Br J Dermatol 1994;130:453-459.818610910.1111%2Fj.1365-2133.1994.tb03377.x Giorno R, Lieber J, Claman HM: Ultrastructural evidence for mast cell activation in a case of neurofibromatosis. Neurofibromatosis 1989;2:35-41.2517021 Smirnov AV: Immunomorphologic study of the extracellular matrix in neurofibroma and benign schwannoma. Arkh Patol 1991;53:40-47.1859281 Enomoto DNH, Mekkes JR, Bossuyt PMM, Hoekzema R, Bos JD: Quantification of cutaneous sclerosis with a skin elasticity meter in patients with generalized scleroderma. J Am Acad Dermatol 1996;35:381-387.878427310.1016%2FS0190-9622%2896%2990601-5 Pans A: Nouvelles perspectives dans l'étiologie des hernies de l'aine. Chirurgie 1999;124:288-297.1042930310.1016%2FS0001-4001%2899%2980095-6 Martolo O, Henry F, Piérard GE: Seuil liminaire de la perception d'un étirement cutané. Acta Derm Venereol 2001;128:119-122. Nikkels-Tassoudji N, Henry F, Piérard-Franchimont C, Piérard GE: Computerized evaluation of skin stiffening in scleroderma. Eur J Clin Invest1996;26:457-460.881715810.1046%2Fj.1365-2362.1996.154303.x Pans A, Piérard GE, Albert A, Desaive C: Adult groin hernias: new insight into their biomechanical characteristics. Eur J Clin Invest 1997;27:863-868.937376710.1046%2Fj.1365-2362.1997.2050752.x Atit RP, Crowe MJ, Greenhalgh DG, Wenstrup RJ, Ratner N: The NF1 tumor suppressor regulates mouse skin wound healing, fibroblast proliferation, and collagen deposited by fibroblasts. J Invest Dermatol 1999;112:835-842.1038372710.1046%2Fj.1523-1747.1999.00609.x Ingram DA, Hiatt K, King AJ, et al: Hyperactivation of p21(ras) and the hematopoietic-specific Rho GTPase, Rac2, cooperate to alter the proliferation of neurofibromin-deficient mast cells in vivo and in vitro. J Exp Med 2001;194:57-69.1143547210.1084%2Fjem.194.1.57 Cichowski K, Jacks T: NF1 tumor suppressor gene function: narrowing the GAP. Cell 2001;104:593-604.1123941510.1016%2FS0092-8674%2801%2900245-8 Karnovel SL, Kallioinen M, Ylä-Outinen H, Pöyjönen M, Oikarinen A, Peltonen J: Occult neurofibroma and increased S 100 protein in the skin of patients with neurofibromatosis type 1: new insight to the etiopathomechanism of neurofibromas. Arch Dermatol 2000;136:1207-1209.1103076610.1001%2Farchderm.136.10.1207 Konomi H, Arima M, Tanaka H, Hayashi T, Ikeda S: Increased deposition of types III and V collagen in neurofibroma tissue from patients with von Recklinghausen disease. Brain Dev 1989;11:378-383.2515769 Piérard GE, Nikkels-Tassoudjin N, Piérard-Franchimont C: Influence of the test area on the mechanical properties of skin. Dermatology 1995;191:9-15.858949910.1159%2F000246472 Henry F, Piérard-Franchimont C, Pans A, Piérard GE: Striae distensae of pregnancy. An in vivo biomechanical evaluation. Int J Dermatol 1997;36:506-508.926874710.1046%2Fj.1365-4362.1997.00041.x Piérard-Franchimont C, Henry F, Crielaard JM, Piérard GE: Mechanical properties of skin in recombinant human growth factor abusers among adult bodybuilders. Dermatology 1996;192:389-392.886438810.1159%2F000246427 Reed N, Gutmann DH: Tumorigenesis in neurofibromatosis: new insights and potential therapies. Trends Mol Med 2001;7:157-162.1128693910.1016%2FS1471-4914%2801%2901955-4 Dobrev H: Use of Cutometer to assess epidermal hydratation. Skin Res Technol 2000;6:239-244.1142896310.1034%2Fj.1600-0846.2000.006004239.x National Institutes of Health Consensus Development Conference: Neurofibromatosis. Conference statement. Arch Neurol 1988;45:575-578.3128965 Henry F, Van Look R, Goffin V, Fissette J, Piérard GE: Mechanical properties of skin and liposuction. Dermatol Surg 1996;22:566-568.864647310.1016%2F1076-0512%2895%2900057-7 Deleixhe-Mauhin F, Piérard-Franchimont C, Rorive G, Piérard GE: Influence of chronic haemodialysis on the mechanical properties of the skin. Clin Exp Dermatol 1994;19:130-133.805014110.1111%2Fj.1365-2230.1994.tb01140.x Von Deimling A, Krone W, Menon AG: Neurofibromatosis type 1: pathology, clinical features and molecular genetics. Brain Pathol 1995;5:153-162.767065610.1111%2Fj.1750-3639.1995.tb00589.x Pagnoni A, Kligman AM, Sadiq I, Stoudeyer T: Hypopigmented macules of photodamaged skin and their treatment with topical tretinoin. Acta Derm Venereol1999;79:305-310.1042999010.1080%2F000155599750010724 Tsukahara K, Takema Y, Moriwaki S, Fujimura T, Imayama S, Imokawa G: Carbon dioxide laser treatment promotes repair of the three-dimensional network of elastic fibres in rat skin. Br J Dermatol 2001;144:452-458.1125999810.1046%2Fj.1365-2133.2001.04067.x ref13 ref24 ref12 ref23 ref15 ref14 ref20 ref11 ref22 ref10 ref21 ref2 ref1 ref17 ref16 ref19 ref18 ref8 ref7 ref9 ref4 ref3 ref6 ref5 |
References_xml | – reference: Zhang LQ, Laato M, Muona P, Kalimo H, Peltonen J: Normal and hypertrophic scars: quantification and localization of messenger RNAs for type I, III and VI collagens. Br J Dermatol 1994;130:453-459.818610910.1111%2Fj.1365-2133.1994.tb03377.x – reference: Konomi H, Arima M, Tanaka H, Hayashi T, Ikeda S: Increased deposition of types III and V collagen in neurofibroma tissue from patients with von Recklinghausen disease. Brain Dev 1989;11:378-383.2515769 – reference: Grudeva-Popova J, Dobrev H: Biomechanical measurement of skin distensibility in scleroderma of Buschke with multiple myeloma. Clin Exp Dermatol 2000;25:247-249.1084450810.1046%2Fj.1365-2230.2000.00627.x – reference: Enomoto DNH, Mekkes JR, Bossuyt PMM, Hoekzema R, Bos JD: Quantification of cutaneous sclerosis with a skin elasticity meter in patients with generalized scleroderma. J Am Acad Dermatol 1996;35:381-387.878427310.1016%2FS0190-9622%2896%2990601-5 – reference: Ingram DA, Hiatt K, King AJ, et al: Hyperactivation of p21(ras) and the hematopoietic-specific Rho GTPase, Rac2, cooperate to alter the proliferation of neurofibromin-deficient mast cells in vivo and in vitro. J Exp Med 2001;194:57-69.1143547210.1084%2Fjem.194.1.57 – reference: Von Deimling A, Krone W, Menon AG: Neurofibromatosis type 1: pathology, clinical features and molecular genetics. Brain Pathol 1995;5:153-162.767065610.1111%2Fj.1750-3639.1995.tb00589.x – reference: Dobrev H: In vivo study of skin mechanical properties in psoriasis vulgaris. Acta Derm Venereol 2000;80:263-266.1102885810.1080%2F000155500750012135 – reference: Pans A: Nouvelles perspectives dans l'étiologie des hernies de l'aine. Chirurgie 1999;124:288-297.1042930310.1016%2FS0001-4001%2899%2980095-6 – reference: National Institutes of Health Consensus Development Conference: Neurofibromatosis. Conference statement. Arch Neurol 1988;45:575-578.3128965 – reference: Chanoki M, Ishii M, Fukai K, Kobayashi H, Hamada T, Muragaki Y, Ooshima A: Immunohistochemical localization of type I, III, IV, V, and VI collagens and laminin in neurofibroma and neurofibrosarcoma.Am J Dermopathol 1991;13:365-373. – reference: Smirnov AV: Immunomorphologic study of the extracellular matrix in neurofibroma and benign schwannoma. Arkh Patol 1991;53:40-47.1859281 – reference: Reed N, Gutmann DH: Tumorigenesis in neurofibromatosis: new insights and potential therapies. Trends Mol Med 2001;7:157-162.1128693910.1016%2FS1471-4914%2801%2901955-4 – reference: Deleixhe-Mauhin F, Piérard-Franchimont C, Rorive G, Piérard GE: Influence of chronic haemodialysis on the mechanical properties of the skin. Clin Exp Dermatol 1994;19:130-133.805014110.1111%2Fj.1365-2230.1994.tb01140.x – reference: Karnovel SL, Kallioinen M, Ylä-Outinen H, Pöyjönen M, Oikarinen A, Peltonen J: Occult neurofibroma and increased S 100 protein in the skin of patients with neurofibromatosis type 1: new insight to the etiopathomechanism of neurofibromas. Arch Dermatol 2000;136:1207-1209.1103076610.1001%2Farchderm.136.10.1207 – reference: Henry F, Piérard-Franchimont C, Pans A, Piérard GE: Striae distensae of pregnancy. An in vivo biomechanical evaluation. Int J Dermatol 1997;36:506-508.926874710.1046%2Fj.1365-4362.1997.00041.x – reference: Nikkels-Tassoudji N, Henry F, Piérard-Franchimont C, Piérard GE: Computerized evaluation of skin stiffening in scleroderma. Eur J Clin Invest1996;26:457-460.881715810.1046%2Fj.1365-2362.1996.154303.x – reference: Henry F, Van Look R, Goffin V, Fissette J, Piérard GE: Mechanical properties of skin and liposuction. Dermatol Surg 1996;22:566-568.864647310.1016%2F1076-0512%2895%2900057-7 – reference: Lakkis MM, Tennekoon GI: Neurofibromatosis type 1: answers from animal models. J Neurosci Res 2001;65:191-194.1149435310.1002%2Fjnr.1142 – reference: Henry F, Goffin V, Piérard-Franchimont C, Piérard GE: Mechanical properties of skin in Ehlers-Danlos syndrome, types I, II and III. Pediatr Dermatol 1996;13:464-467.898705410.1111%2Fj.1525-1470.1996.tb00725.x – reference: Fong SSL, Hung LK, Cheng JCY: The Cutometer and ultrasonography in the assessment of postburn hypertrophic scar - A preliminary study. Burns 1997;23:S12-S18. – reference: Martolo O, Henry F, Piérard GE: Seuil liminaire de la perception d'un étirement cutané. Acta Derm Venereol 2001;128:119-122. – reference: Giorno R, Lieber J, Claman HM: Ultrastructural evidence for mast cell activation in a case of neurofibromatosis. Neurofibromatosis 1989;2:35-41.2517021 – reference: Pans A, Piérard GE, Albert A, Desaive C: Adult groin hernias: new insight into their biomechanical characteristics. Eur J Clin Invest 1997;27:863-868.937376710.1046%2Fj.1365-2362.1997.2050752.x – reference: Pagnoni A, Kligman AM, Sadiq I, Stoudeyer T: Hypopigmented macules of photodamaged skin and their treatment with topical tretinoin. Acta Derm Venereol1999;79:305-310.1042999010.1080%2F000155599750010724 – reference: Peltonen J, Penttinnen R, Larjava H, Aho HJ: Collagens in neurofibromas and neurofibroma cell cultures. Ann NY Acad Sci1986;486:260-270.310539110.1111%2Fj.1749-6632.1986.tb48079.x – reference: Piérard GE, Nikkels-Tassoudjin N, Piérard-Franchimont C: Influence of the test area on the mechanical properties of skin. Dermatology 1995;191:9-15.858949910.1159%2F000246472 – reference: Piérard-Franchimont C, Henry F, Crielaard JM, Piérard GE: Mechanical properties of skin in recombinant human growth factor abusers among adult bodybuilders. Dermatology 1996;192:389-392.886438810.1159%2F000246427 – reference: Tsukahara K, Takema Y, Moriwaki S, Fujimura T, Imayama S, Imokawa G: Carbon dioxide laser treatment promotes repair of the three-dimensional network of elastic fibres in rat skin. Br J Dermatol 2001;144:452-458.1125999810.1046%2Fj.1365-2133.2001.04067.x – reference: Cichowski K, Jacks T: NF1 tumor suppressor gene function: narrowing the GAP. Cell 2001;104:593-604.1123941510.1016%2FS0092-8674%2801%2900245-8 – reference: Atit RP, Crowe MJ, Greenhalgh DG, Wenstrup RJ, Ratner N: The NF1 tumor suppressor regulates mouse skin wound healing, fibroblast proliferation, and collagen deposited by fibroblasts. J Invest Dermatol 1999;112:835-842.1038372710.1046%2Fj.1523-1747.1999.00609.x – reference: Dobrev H: Use of Cutometer to assess epidermal hydratation. Skin Res Technol 2000;6:239-244.1142896310.1034%2Fj.1600-0846.2000.006004239.x – ident: ref18 doi: 10.1016%2F1076-0512%2895%2900057-7 – ident: ref16 doi: 10.1159%2F000246427 – ident: ref7 doi: 10.1046%2Fj.1365-2362.1997.2050752.x – ident: ref17 doi: 10.1034%2Fj.1600-0846.2000.006004239.x – ident: ref5 doi: 10.1159%2F000246472 – ident: ref6 doi: 10.1001%2Farchderm.136.10.1207 – ident: ref3 doi: 10.1111%2Fj.1750-3639.1995.tb00589.x – ident: ref9 doi: 10.1111%2Fj.1525-1470.1996.tb00725.x – ident: ref14 doi: 10.1046%2Fj.1365-2230.2000.00627.x – ident: ref19 doi: 10.1046%2Fj.1365-2133.2001.04067.x – ident: ref12 doi: 10.1046%2Fj.1365-2362.1996.154303.x – ident: ref21 doi: 10.1111%2Fj.1749-6632.1986.tb48079.x – ident: ref2 doi: 10.1016%2FS0092-8674%2801%2900245-8 – ident: ref15 doi: 10.1111%2Fj.1365-2230.1994.tb01140.x – ident: ref24 doi: 10.1002%2Fjnr.1142 – ident: ref10 doi: 10.1080%2F000155500750012135 – ident: ref4 doi: 10.1016%2FS0190-9622%2896%2990601-5 – ident: ref22 doi: 10.1084%2Fjem.194.1.57 – ident: ref11 doi: 10.1080%2F000155599750010724 – ident: ref13 doi: 10.1046%2Fj.1365-4362.1997.00041.x – ident: ref20 doi: 10.1111%2Fj.1365-2133.1994.tb03377.x – ident: ref23 doi: 10.1046%2Fj.1523-1747.1999.00609.x – ident: ref1 doi: 10.1016%2FS1471-4914%2801%2901955-4 – ident: ref8 doi: 10.1016%2FS0001-4001%2899%2980095-6 |
SSID | ssj0026716 |
Score | 1.775993 |
Snippet | Neurofibromatosis type 1 (NF1) is a frequent autosomal dominant disease characterized by cutaneous benign tumors called neurofibromas. Surgery takes an... |
SourceID | proquest pubmed crossref karger |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 22 |
SubjectTerms | Adolescent Adult Elasticity Female Humans Male Middle Aged Neurofibromatosis 1 - physiopathology Original Paper Rheology Skin - physiopathology Skin Neoplasms - physiopathology |
Title | Evaluation of Skin Viscoelasticity in Type 1 Neurofibromatosis Patients |
URI | https://karger.com/doi/10.1159/000089140 https://www.ncbi.nlm.nih.gov/pubmed/16247246 https://www.proquest.com/docview/225269497 https://www.proquest.com/docview/70197589 |
Volume | 19 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1660-5535 dateEnd: 20231001 omitProxy: true ssIdentifier: ssj0026716 issn: 1660-5527 databaseCode: 7X7 dateStart: 20040101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: http://www.proquest.com/pqcentral?accountid=15518 eissn: 1660-5535 dateEnd: 20231001 omitProxy: true ssIdentifier: ssj0026716 issn: 1660-5527 databaseCode: BENPR dateStart: 20040101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8QwEB7UFfEivl0faxAPXop9JGlzEpVdF0ERUdlbyasgylbtevDfO2mzXQ_qpYc0pDAzyXyTmX4DcGzCWGaF5kGcxiagksaBMtQVO4Q4qpgVuq62uOXDR3o9YiNfm1P5ssrpmVgf1KbU7o78FO3O_XQp0rO398A1jXLJVd9BYx46ESIVZ9TpaBZv8bTufBpxHgaOaMwTC6EDrzkbMxG5K48f7mjxxVVff_wNNmunM1iFFY8WyXmj3jWYs-N1WLrx-fANuOq3ZN2kLIjrpEWenitdWgTFrl568kVwyAWbJCINEQfGxyXC1LJ6rshdw6pabcLjoP9wOQx8a4RA4yabBAphnQ1FaosokVRwIa1VnDGJAYpizGiNgUhBJR4hcREpa4SMOHNZ01ShhzfJFiyMy7HdAWIyjRhQSZtklLICl0mEEWFiMxZrfHbhZCqhXHvecNe-4jWv4wcm8laYXThqp741ZBm_TdpoxNxO8cN7U6HnfhtVeav0Lhy2b9H-XVJDjm35WeWOTh5jHtGF7UZTsy_zmKYx5bv_rrwHy7NblX1YmHx82gPEGRPVq62pB52L_u3d_TdEm9BZ |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LT9VAFD5BNMKGqAheQJkYTdw0tNOZaWdhCFHwIo-4AHN3ZV5NiOYW6SWEH8V_9Jy-rgt1x6aL6WSanPmm8505Z74D8M7H3OSlUxHPuI-EETyyXlCyQ4ytVgbtmmyLUzU-F18ncrIA9_1dGEqr7P-JzY_aV47OyHcQd3TpUme7V78iKhpFwdW-gkaLiqNwd4seW_3x8DNO73vOD_bPPo2jrqhA5BCes8giIQqxzkKZpEZopU0IVklpkNpbKb1zSOFLYXDx8TKxwWuTKEnxxszi3uhTHPcRPBZpLEiqP5vM_TuVNZVWE6XiiITNOiEjJAyNRmSuEzpi-WP7e_KDsr2v_01um03u4BmsdOyU7bVweg4LYfoCnp508fdV-LI_iIOzqmRUuYt9v6xdFZCEU3727I5hEzm3LGGt8Af64xXS4qq-rNm3VsW1fgnnD2K1NVicVtPwCpjPHXJOa0KaCyFLHCbVXsdpyCV3-BzBh95Chet0yqlcxs-i8VekLgZjjuDt0PWqFef4W6fV1sxDl655szd60S3buhhANoLt4S2uNwqimGmobuqC5OvRx9IjWG9nav5lxUXGhdr478jbsDQ-Ozkujg9PjzZheX6iswWLs-ub8Bo5zsy-aZDF4OKhofwbhz8LUg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Evaluation+of+skin+viscoelasticity+in+type+1+neurofibromatosis+patients&rft.jtitle=Skin+pharmacology+and+physiology&rft.au=Mimoun%2C+N&rft.au=Razzouq%2C+N&rft.au=Wolkenstein%2C+P&rft.au=Moreno%2C+J+C&rft.date=2006-01-01&rft.issn=1660-5527&rft.volume=19&rft.issue=1&rft.spage=22&rft_id=info:doi/10.1159%2F000089140&rft_id=info%3Apmid%2F16247246&rft.externalDocID=16247246 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1660-5527&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1660-5527&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1660-5527&client=summon |